Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Current treatment guidelines for the management of recurrent glioblastoma (rGBM) are far from definitive, and the prognosis remains dismal. Despite recent advancements in the pharmacological and surgical fields, numerous doubts persist concerning the optimal strategy that clinicians should adopt for...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Augusto, Colamaria, Antonio, Fochi, Nicola Pio, Sacco, Matteo, Landriscina, Matteo, Parbonetti, Giovanni, de Notaris, Matteo, Coppola, Giulia, De Santis, Elena, Giordano, Guido, Carbone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405902/
https://www.ncbi.nlm.nih.gov/pubmed/36009473
http://dx.doi.org/10.3390/biomedicines10081927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405902/
https://www.ncbi.nlm.nih.gov/pubmed/36009473
http://dx.doi.org/10.3390/biomedicines10081927

Ejemplares similares